The use of antibiotics as secondary prevention for cardiac events

Pharmacotherapy

Volumn 24, Issue 11, 2004, Pages 1652-1653

  Lim, Lyn Li ^a   Kotsanas, Despina ^b   Ostergaard, Lars ^c   Woolley, Ian ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Antibiotics; Cardiac event; Coronary event; Macrolides

Indexed keywords

ANTIBIOTIC AGENT; ATORVASTATIN; AZITHROMYCIN; CLARITHROMYCIN; MACROLIDE; PRAVASTATIN; ROXITHROMYCIN;

ANTIBIOTIC THERAPY; ANTICHLAMYDIAL ACTIVITY; CLINICAL PRACTICE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG ACTIVITY; HEART DISEASE; HEART INFARCTION; HUMAN; META ANALYSIS; MORTALITY; SHORT SURVEY; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; UNSTABLE ANGINA PECTORIS;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ATTITUDE OF HEALTH PERSONNEL; CARDIOVASCULAR DISEASES; HUMANS; RANDOMIZED CONTROLLED TRIALS;

EID: 7044250871     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.24.16.1652.50944     Document Type: Short Survey

References (6)

1. Etminan M, Carleton B, Delaney JAC, Padwal R. Macrolide therapy for Chlamydia pneumoniae in the secondary prevention of coronary artery disease: a meta-analysis of randomized controlled trials. Pharmacotherapy 2004;24:338-43.
2. Gimenez-Sanchez F, Butler JC, Jernigan DB, et al. Treating cardiovascular disease with antimicrobial agents: a survey of knowledge, attitudes, and practices among physicians in the United States. Clin Infect Dis 2001;33:171-6.
3. Cannon CP, McCabe CH, Belder R, Breen J, Braunwald E. Design of the pravastatin or atorvastatin evaluation and infection therapy (PROVE IT)-TIMI 22 trial. Am J Cardiol 2002;89:860-1.
4. Jackson LA. Description and status of the azithromycin and coronary events study (ACES). J Infect Dis 2000;181(suppl 3):S579-81.
5. Hansen S, Als-Nielsen B, Damgaard M, Helo OH, Petersen L, Jespersen CM. Intervention with clarithromycin in patients with stable coronary heart disease. Heart Drug 2001;1:14-19.
6. Brown DL, Desai KK, Vakili BA, Nouneh C, Lee HM, Golub LM. Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial. Arterioscler Thromb Vasc Biol 2004;24:733-8.